Aug 6, 2026 06:51AM

Jul 22, 2026 06:50AM

Jul 15, 2026 05:11AM

Jun 16, 2026 06:44AM

Jun 15, 2026 06:50AM

May 13, 2026 05:10AM

May 8, 2026 06:01AM Pharvaris prices $115 million share offering at $29.68 per share

Apr 20, 2026 06:50AM

Apr 6, 2026 07:10AM

Apr 2, 2026 04:35PM

Mar 20, 2026 06:51AM

Mar 18, 2026 09:21AM

Mar 11, 2026 06:50AM

Mar 9, 2026 05:10AM RBC Capital Starts Pharvaris B.V. (PHVS) at Outperform

Mar 2, 2026 06:55AM

Jan 22, 2026 06:42AM

Jan 12, 2026 06:50AM

Dec 4, 2025 06:55AM

Dec 3, 2025 02:49PM

Dec 3, 2025 11:44AM

Dec 3, 2025 06:50AM Pharvaris reports positive results from HAE treatment study

Nov 21, 2025 07:05AM

Nov 19, 2025 04:26AM

Oct 23, 2025 06:44AM

Oct 15, 2025 06:06AM

Oct 8, 2025 04:16PM

Aug 13, 2025 04:07AM

Jul 10, 2025 11:17AM BofA Securities Reiterates Underperform Rating on Pharvaris B.V. (PHVS)

Jul 10, 2025 06:51AM

Jun 27, 2025 06:50AM

Jun 16, 2025 06:50AM

Jun 5, 2025 04:20AM

Jun 2, 2025 06:52AM

Apr 23, 2025 04:23AM

Apr 1, 2025 06:50AM Pharvaris (PHVS) Granted Orphan Designation to Deucrictibant in the EU

Mar 3, 2025 06:50AM

Mar 3, 2025 04:49AM

Feb 18, 2025 04:15AM

Jan 31, 2025 04:40AM

Jan 13, 2025 06:52AM

Oct 16, 2024 06:51AM

Oct 14, 2024 06:08AM Oppenheimer Reiterates Outperform Rating on Pharvaris B.V. (PHVS)

Oct 3, 2024 06:50AM

Sep 19, 2024 09:33AM

Sep 6, 2024 05:07AM

Sep 5, 2024 06:50AM

Sep 5, 2024 06:50AM

Jul 3, 2024 05:54AM

432,617 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All